deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT05077917

Cromolyn Sodium for Treatment of COVID-19 Pneumonia

Sponsor: Texas Tech University Health Sciences Center, El Paso

Conditions COVID-19 Pneumonia COVID-19 Respiratory Infection Pneumonia, Viral
Interventions Cromolyn Sodium Placebo
Updated 10 times since 2021 Last updated: Nov 14, 2024 Started: Nov 15, 2021 Primary completion: May 23, 2024 Completion: May 23, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow enrollment

Other terminated trials from Texas Tech University Health Sciences Center, El Paso

See all terminations from Texas Tech University Health Sciences Center, El Paso

Other COVID-19 Pneumonia trials with similar outcome

Browse all COVID-19 Pneumonia trials

This PHASE3 trial investigates COVID-19 Pneumonia and COVID-19 Respiratory Infection and is currently terminated or withdrawn. Texas Tech University Health Sciences Center, El Paso leads this study, which shows 10 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshotNot Yet Recruiting~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshotNot Yet Recruiting~Apr 2022 – ~Jun 2022 · 2 months · monthly snapshotRecruiting~Jun 2022 – ~Mar 2023 · 9 months · monthly snapshotRecruiting~Mar 2023 – ~Mar 2024 · 12 months · monthly snapshotRecruiting~Mar 2024 – ~Jul 2024 · 4 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshotRecruiting~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshotTerminated~Sep 2025 – present · 12 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Dec 2024 — Sep 2025 [monthly]

    Terminated PHASE3

    Status: Recruiting → Terminated

  3. Sep 2024 — Dec 2024 [monthly]

    Recruiting PHASE3

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE3

  5. Mar 2024 — Jul 2024 [monthly]

    Recruiting PHASE3

▶ Show 5 earlier versions

  1. Mar 2023 — Mar 2024 [monthly]

    Recruiting PHASE3

  2. Jun 2022 — Mar 2023 [monthly]

    Recruiting PHASE3

  3. Apr 2022 — Jun 2022 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  4. Dec 2021 — Apr 2022 [monthly]

    Not Yet Recruiting PHASE3

  5. Nov 2021 — Dec 2021 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Texas Tech University Health Sciences Center, El Paso
Data source: Texas Tech University Health Sciences Center, El Paso

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations